Entry |
|
Name |
Glutamine (USP); L-Glutamine (JP17); Levoglutamide; Endari (TN); Nutrestore (TN) |
Product |
|
Formula |
C5H10N2O3
|
Exact mass |
146.0691
|
Mol weight |
146.1445
|
Structure |

|
Simcomp |
|
Class |
Gastrointestinal agent
DG01975 Agents for peptic ulcer
DG02008 Gastric mucosal protectant
DG02008 Gastric mucosal protectant
Other
DG01672 Amino acid
|
Remark |
Therapeutic category: | 2322 |
Product (mixture): | D04363<JP> |
|
Efficacy |
Anti-ulcerative, Dietary supplement |
Disease |
Sickle cell disease [DS: H00229] |
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AA Amino acids and derivatives
A16AA03 Glutamine
D00015 Glutamine (USP) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Gastrointestinal Agents, Other
Short Bowel Syndrome Agents
Glutamine
D00015 Glutamine (USP)
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Glutamine
D00015 Glutamine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
232 Peptic ulcer agents
2322 Glutamines
D00015 Glutamine (USP); L-Glutamine (JP17)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
L-Glutamine
D00015 Glutamine (USP)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00015 L-Glutamine
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00015
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00015
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 10
1 C1c C 23.8378 -17.4606
2 C1b C 25.0254 -16.7178
3 C6a C 22.6035 -16.7995
4 N1a N 23.8787 -18.8587
5 C1b C 26.2597 -17.3787
6 O6a O 21.4451 -17.5952
7 O6a O 22.6209 -15.4015
8 C5a C 27.4472 -16.6416
9 N1a N 28.6814 -17.3027
10 O5a O 27.4704 -15.2435
BOND 9
1 1 2 1
2 1 3 1
3 1 4 1 #Down
4 2 5 1
5 3 6 1
6 3 7 2
7 5 8 1
8 8 9 1
9 8 10 2
|